DAILYSCREEN

supergoop, llc🇨🇦 Health Canada

Approval Id: 2f749660106d22d4
Drug Approval Canada Name: DAILYSCREEN
Product Name: DAILYSCREEN
Status: Cancelled Post Market
Status Date: 2024-06-01
Original Market Date: 2020-05-05
Din: 02494957
Drug Class: Human
Dosage Form: Cream
Route Of Administration: Topical
Schedule: OTC
Ahfs: 84:80.00
Atc Original: D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name: d 02 ba 30
Aig Number: 0350284014
Company Name: supergoop, llc
Company Address: 200 E. Grayson, Suite 110, San Antonio, Texas, United States

AVOBENZONE

2.5 % / W/W

OCTISALATE

5 % / W/W

HOMOSALATE

8 % / W/W

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2f749660106d22d4

Type

Standard